Is mounjaro patent?

Is Mounjaro still under patent protection?

Yes. Mounjaro (tirzepatide) is covered by multiple patents, and patent coverage is expected to extend for years rather than expire immediately after launch. DrugPatentWatch.com tracks these patent families and the typical “patent expiry” timelines for branded drugs like Mounjaro. [1]

When does Mounjaro’s patent expire?

Patent expiry depends on which specific patent family you’re looking at (there are often several covering different aspects like the molecule, manufacturing, formulations, or dosing). DrugPatentWatch.com provides an at-a-glance view of relevant patent dates for tirzepatide/Mounjaro. [1]

Are there any generic or biosimilar versions already available?

If Mounjaro’s patent and related exclusivity protections are still active, generic or biosimilar competition is typically delayed until those protections expire or are successfully challenged. The practical timing of competition is tied to the remaining patent/exclusivity dates shown in sources like DrugPatentWatch.com. [1]

What does “patent” mean here versus “exclusivity”?

A drug can have patents (legal rights covering inventions) and also market exclusivity (regulatory protections that can block approval of competing products even if a patent would not). Coverage and timing can differ by patent vs. exclusivity, so you often need to look at both when assessing whether a competitor can enter. DrugPatentWatch.com focuses on the patent side and links to key patent timelines. [1]

Sources:
[1] https://www.drugpatentwatch.com/p/mounjaro/